The need for long-term treatment in the mouse lymphoma assay

Mutagenesis

Volumn 14, Issue 1, 1999, Pages 23-29

  Honma, Masamitsu ^a   Zhang, Li Shi ^a,b   Sakamoto, Hiroko ^a   Ozaki, Masayasu ^a   Takeshita, Kenji ^a   Momose, Maki ^a   Hayashi, Makoto ^a   Sofuni, Toshio ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL AGENT; CLASTOGEN; COLCHICINE; MUTAGENIC AGENT; NUCLEOSIDE; NUCLEOSIDE ANALOG; PENTOSTATIN; POISON; THEOPHYLLINE; THYMIDINE KINASE; TRIFLURIDINE; VINBLASTINE SULFATE; ZALCITABINE;

ANIMAL CELL; ARTICLE; BIOASSAY; CELL CULTURE; CELL CYCLE; CHROMOSOME ABERRATION; CHROMOSOME SEGREGATION; GENE MUTATION; GENOTOXICITY; LYMPHOMA; MOUSE; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL;

ANIMALS; CELL SURVIVAL; CHROMOSOMES; LEUKEMIA L5178; MICE; MUTAGENICITY TESTS; MUTAGENS; THYMIDINE KINASE; TIME FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA; MAMMALIA;

EID: 0032963281     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/14.1.23     Document Type: Article

References (57)

1. Aaron, C.S., Bolcsfoldi, G., Glatt, H.R., Moore, M., Nishi, Y., Stankowski, L., Jr, Theiss, J. and Thompson, E. (1994) Mammalian cell gene mutation assays working group report. Mutat. Res., 312, 235-239.
2. Amacher, D.E. and Turner, G.N. (1982) Mutagenic evaluation of carcinogens in the L5178Y/TK assay utilizing postmitochondrial fractions (S9) from normal rat liver. Mutat. Res., 97, 49-65.
3. Blazak, B.F., Los, F.J., Rudd, C.J. and Caspary, W.J. (1989) Chromosome analysis of small and large L5178Y mouse lymphoma cell colonies: comparison of trifluorothymidine-resistant and unselected cell colonies from mutagen-treated and control culture. Mutat. Res., 224, 197-208.
4. Caspary, W., Langenbach, R., Penman, B.W., Crespi, C., Myhr, B.C. and Mitchell, A.D. (1988) The mutagenic activity of selected compounds at the TK locus: rodent vs. human cells. Mutat. Res., 196, 61-81.
5. CEC/EU (1989) The Rules Governing Medicinal Products in the European Community, Vol. III. Guidelines on the Quality, Safety and Efficacy of Medical Products for Human Use. Commission of the European Communities, Brussels, Belgium, p. 103.
6. Chetelat, A. (1987) Hoffman-La Roche Research Report no. B-153′750. Hoffman-La Roche, Basel, Switzerland.
7. Clive, D. and Spector, J.F.S. (1975) Laboratory procedure for assessing specific locus mutations at the tk locus in cultured L5178Y mouse lymphoma cells. Mutat. Res., 31, 17-29.
8. Clive, D., Johnson, K.O., Spector, J.F.S., Batson, A.C. and Brown, M.M.M. (1979) Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system. Mutat. Res., 59, 61-108.
9. Clive, D., Turner, N.T., Krehl, R. and Eyre, J. (1985) The mouse lymphoma assay may also be used as a chromosome aberration assay. Environ. Mutagen., 7 (suppl. 3), 33.
10. Clive, D., Clover, P., Applegate, M. and Hozier, J. (1990) Molecular aspects of chemical mutagenesis in L5178Y/tk+/- mouse lymphoma cells. Mutagenesis, 5, 191-197.
11. Clive, D., Bolcsfoldi, G., Clements, J., Cole, J., Honma, M., Majeska, J., Moore, M., Muller, L., Myhr, B., Oberly, T., Odelhkim, M.C., Rudd, C., Shimada, H., Sofuni, T., Thybaud, V. and Wilcox, P. (1995) Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon. May 7, 1994. Environ. Mol. Mutagen., 25, 165-168.
12. Cochrane, J.E. and Skopek, T.R. (1994) Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4,-diepoxybutane and 3,4-epoxy-1.2-butanediol in cultured human lymphoblasts. Carcinogenesis, 15, 713-717.
13. Cole, J., Arlett, C.F., Green, M.H.L., Lowe, J. and Muriel, W. (1983) A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cells. Mutat. Res., 111, 371-386.
14. Combes, R.D., Stopper, H. and Caspary, W.J. (1995) The use of L5178Y mouse lymphoma cells to assess the mutagenic, clastogenic and aneugenic properties of chemicals. Mutagenesis, 10, 403-408.
15. DHSS UK (1989) Guidelines for Testing Chemicals for Mutagenicity: DHSS Report on Health and Social Subjects, No. 35. HMSO, London, UK.
16. Federal Register (1993) Draft Revised Toxicological Principles for the Safety Assessment of Direct Food and Color Additives Used in Food. FDA/ CFSAN, Washington DC, USA.
17. Galloway, S.M., Armstrong, M.J., Reuben, C., Colman, S., Brown, B.C.C., Bloom, A.D., Nakamura, F., Ahmed, M., Duk, S., Rimpo, J., Margolin, B.H., Resnick, M.A., Anderson, B. and Zeiger, E. (1987) Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluation of 108 chemicals. Environ. Mol. Mutagen., 10, 1-175.
18. Galloway, S.M., Aardema, M.J., Ishidate, M., Jr, Ivett, J.L., Kirkland, D.J., Morita, T., Mosesso, P. and Sofuni, T. (1994) Report from working group on in vitro tests for chromosomal aberrations. Mutat. Res., 312, 241-261.
19. Garriot, M.L., Casciano, D.A., Schechtman, L.M. and Probst, G.S. (1995) International workshop on mouse lymphoma assay testing practices and data interpretations: Portland, Oregon, May 7, 1994. Environ. Mol. Mutagen., 25, 162-164.
20. Hoppe.H., Call, K.M., Leong, P.-M. and Thilly, W.G. (1991) Cell-cycle dependent mutation of human lymphoblasts: bromodeoxyundine and butyl methanesulfonate. Mutat. Res., 250, 411-421.
21. Honma, M. and Little, J.B. (1995) Recombinogenic activity of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human lymphoblastoid cells. Carcinogenesis, 16, 1717-1722.
22. Honma, M., Hayashi, M., Shimada, H., Tanaka, N., Wakuri, S., Awogi, T., Yamamoto, K.I., Ushio-Kodani, N., Nishi, Y., Nakadate, M. and Sofuni, T. (1999) Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test. Mutagenesis, 14, 5-22.
23. Hsie, A.W., O'Neill, J.P., Couch.D.B., San Sebastian, J.R., Brimer, P.A., Machanoff, R., Fuscoe, J.C., Riddle, J.C., Li, A.P. and Hsie, M.H. (1978) Quantitative analysis of radiation-and chemical-induced lethality and mutagenesis in Chinese hamster ovary cells. Radiat. Res., 76, 471-492.
24. ICH (1994) Technical symposium: Safety, Session 1: Harmonization of genotoxicity testing requirements. In D'Arcy, P.F. and Harron, D.W.G. (eds). Proceedings of the Set the International Conference on Harmonization of Technical Requirements for Registration of Registration for Human Use, Orlando 1993. The Queen's University, Belfast, UK, pp. 221-257.
25. ICH (1996) Technical symposium: Safety, Session 4: Genotoxicity Testing. In D'Arcy, P.F. and Harron, D.W.G. (eds). Proceedings of the Third International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Yokohama, 1995. The Queen's University, Belfast, UK, pp. 303-329.
26. ICH (1997) Technical workshop III: Non-clinical safety testing for new medical products. Session 1: Genotoxicity. In D'Arcy, P.F. and Harron, D.W.G. (eds). Proceedings of the Fourth International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Brussels, 1997. The Queen's University, Belfast, UK, pp. 236-261.
27. Ishidate, M., Jr (1987) Data Book of Chromosome Aberration Tests In Vitro. LIC/Elsevier, Tokyo, Japan.
28. Ishidate, M., Jr (1988) A proposed battery of tests for the initial evaluation of the mutagenic potential of medicinal and industrial chemicals. Mutat. Res., 205, 397-407.
29. Jotz, M.M. and Mitchell, A.D. (1981) Effect of 20 coded chemicals on the forward mutation frequency at the thymidine kinase locus in L5178Y mouse lymphoma cells. Prof. Mutat. Res., 1, 580-593.
30. 6-hydroxyadenine to TK6 human lymphoblast cells. Mutat. Res., 253, 91-95.
31. Majeska, J.B. and Matheson, D.W. (1990) Development of an optimal S9 activation mixture for the L5178YTK+/- mouse lymphoma mutation assay. Environ. Mol. Mutagen., 16, 311-319.
32. Matsuoka, A., Yamakage, K., Kusakahe, H., Wakuri, S., Asakura.M., Noguchi, T., Sugiyama, T., Shimada, H., Nakayama, S., Kasahara, Y., Takahashi, Y., Miura, K.F., Hatanaka, M., Ishidate Jr., M., Morita, T. Watanabe, K., Hara, M., Odawara, K., Tanaka, N., Hayashi, M. and Sofuni, T. (1996) Re-evaluation of chromosomal aberration induction on nine mouse lymphoma assay 'unique positive' NTP carcinogens. Mutat. Res., 369, 243-252.
33. McGregor, D.B., Brown, A., Cattanach, P., Edwards, I., McBride, D. and Caspary, W.J. (1988a) Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay II: 18 coded chemicals. Environ. Mol. Mutagen., 11, 91-118.
34. McGregor, D.B., Brown, A.G. Cattanach, P., Edwards, I., McBridge, D., Riach, C. and Caspary, W.J. (1988b) Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay: III. 72 coded chemicals. Environ. Mol. Mutagen., 12, 85-154.
35. McGregor, D.B., Brown, A.G. Howgate, S., McBridge, D., Riach, C. and Caspary, W.J. (1991) Responses of the L5I78Y mouse lymphoma cell forward mutation assay: V. 27 coded chemicals. Environ. Mol. Mutagen., 17, 196-219.
36. MHW Japan (1990) Guideline for Toxicity Studies of Drugs Manual. Ministry of Health and Welfare. Tokyo, Japan.
37. +/- mouse lymphoma specific gene and chromosomal mutation assay; a phase III report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 394, 177-303.
38. Moore, M.M. and Clive, D. (1982) The quamilalion of TK-/- and HGPRT-mutants of L5178Y/TK+/- mouse lymphoma cells at varying times post̂ treatment. Environ. Mutagen., 4, 499-519.
39. Moore, M.M. and Howard, B.E. (1982) Quantitation of small colony trifluorothymidine-resistant mutants of L5178Y/TK+/- mouse lymphoma cells in RPMI-1640 medium. Mutat. Res., 104, 287-294.
40. Moore, M.M., Clive, D., Hozier, J.C., Howard, B.E., Batson, A.G., Turner, N.T. and Sawyer, J. (1985) Analysis of trifluorothymidine-resistant (TFT) mutants of L5178Y/TK+/- mouse lymphoma cells. Mutat. Res., 151, 161-174.
41. Moore-Brown, M.M., Clive, D., Howard, B.E., Batson, A.G. and Johnson, K.O. (1981) The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells. Mutat. Res., 85, 363-378.
42. Myhr, B.C. and Caspary, W.J. (1988) Evaluation of L5178Y mouse lymphoma cell mutagenesis assay: intralaboratory results for sixty-three chemicals tested at Litton Bionetics, Inc. Environ. Mol. Mutagen., 12, 103-194.
43. Myhr, B.C. and Caspary, W.J. (1991) Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: results for 31 coded compounds in the National Toxicology Program. Environ. Mol. Mutagen., 18, 51-83.
44. Myhr, B.C., McGregor, D., Bowers, L., Riach, C., Brown, A.G., Edward, I., McBride, D., Martin, R. and Caspary, W.J. (1990) L5178Y mouse lymphoma cell mutation assay results with 41 compounds. Environ. Mol. Mutagen., 18, 138-167.
45. Oberly, T.J., Bewsey, B.J. and Probst, G.S. (1984) An evaluation of the L5178Y TK+/- mouse lymphoma forward mutation assay using 42 chemicals. Mutat. Res., 125, 291-306
46. O'Donoghue, J.I., Haworth, S.R., Curren, R.D., Kirby, P.E., Lawlor, T. Moran, E.J., Phillips, R.D., Putnam, D.L., Rogers-Back, A.M., Slesinski, R.S. and Thilagar, A. (1988) Mutagenicity studies on ketone solvents: methyl ethyl ketone, methyl isobutyl ketone, and isophorone. Mutat. Res., 206. 149-161.
47. OECD (1997) Updated Genotoxicity Test Guidelines. OECD, Paris, France.
48. Otsuka, M., Ogura, M., Okada, M., Inai, T., Kajiwara, Y. Anzinin, S., Kubo, K., Kikuno, T., Shiraishi, H., Kakimoto, K., Shigaki, T., Kuwata, S. and Umehashi, S. (1991) Mutagenicity studies of YK-176. Kiso To Rinsyo, 25, 1311-1320.
49. Segawa, M., Nadamitsu, S., Kondo, K. and Yoshizaki, I. (1979) Chromosomal aberration of Don lung cells of Chinese hamster after exposure to vinblastine in vitro. Mutat. Res., 66, 99-102.
50. Simpson, D.G. and Margolin, B.H. (1986) Recursive nonparametric testing for dose-response relationships subject to downturns at high doses. Biometrika, 73, 589-596.
51. Simpson, D.G. and Margolin, B.H. (1990) Nonparametric testing for dose-response curves subject to down turns: asymptotic power considerations. Ann. Statist., 18, 373-390.
52. Sofuni, T., Honma, M., Hayashi, M., Shimada, H., Tanaka, N., Wakuri, S., Awogi, T., Yamamoto, K.I., Nishi, Y. and Nakadate, M. (1996) Detection of in vitro clastogens and spindle poisons by the mouse lymphoina assay using the microwell method: interim report of an international collaborative study. Mutagenesis, 11, 349-355.
53. Sofuni, T., Wilcox, P., Shimada, H., Clements, J., Honma, M., Clive, D., Green, M., Thybaud, V., San, R.H.C., Elliot, B.M. and Muller.L. (1997) Meeting report on protocol issues regarding the use of the microwell method discussed in the mouse lymphoma workshop: Victoria BC. Canada. March 27, 1996. Environ. Mol. Mutagen., 29, 434-438.
54. Tennant, R.W., Margolin, B.H., Shelby, M.D., Zeiger, E., Haseraan, J.K., Spalding, J., Caspary, W., Resnick, M., Stasiewics, S., Anderson, B. and Minor, R. (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science, 236, 933-941.
55. Turner, N.T., Batson, A.J. and Clive, D. (1984) Procedure for the L5178Y/ TK+/-to TK-/-mouse lymphoma cell mutagenicity assay. In Kilbey, B.J., Legator, M., Nichols, W. and Ramel, C. (eds). Handbook of Mutagenicity Test Procedure. Elsevier, Amsterdam, The Netherlands, pp. 239-268.
56. Zeiger, E., Haseman, J.K., Shelby, M.D., Margolin, B.H. and Tennant, R.W. (1990) Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals. Environ. Mol. Mutagen., 16, 1-14.
57. Zhang, L.-S., Honma, M., Matsuoka, A., Suzuki, T., Sofuni, T. and Hayashi, M. (1996) Chromosome painting analysis of spontaneous and methylmethanesulfonate-induced trifluorothymidine-resistant L5178Y cell colonies. Mutat. Res., 370, 181-190.